A randomized phase II clinical trial of gemcitabine, oxaliplatin, erlotinib combination chemotherapy versus gemcitabine and erlotinib in previously untreated patients with locally advanced or metastatic pancreatic cancer
- All Author(s)
- S. H. Lim
; J. Yun
; M. Y. Lee
; H. J. Kim
; K. H. Kim
; S. H. Kim
; S. C. Lee
; S. B. Bae
; C. K. Kim
; N. Lee
; K. T. Lee
; S. K. Park
; D. S. Hong
; H. J. Choi
; J. H. Moon
- Intsitutional Author(s)
- 김한조; 이상철; 배상병; 이규택
- Issued Date
- 2018
- Type
- Conference
- Conference Name
- Gastrointestinal Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO)
- Conference Date
- 43118
- dc_citation_conferenceCountry
- San Francisco, CA, United States
- Citation Publisher
- American Society of Clinical Oncology
- Citation Title
- Journal of Clinical Oncology. Volume 36, Number 4_suppl
- Citation Start Page
- 344
- Citation End Page
- 344
- Language(ISO)
- eng
- DOI
- 10.1200/JCO.2018.36.4_suppl.344
- URI
- http://schca-ir.schmc.ac.kr/handle/2022.oak/4540
- 공개 및 라이선스
-
- 파일 목록
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.